CN107007755A - 一种跌打喷雾剂的制备方法 - Google Patents

一种跌打喷雾剂的制备方法 Download PDF

Info

Publication number
CN107007755A
CN107007755A CN201710227618.5A CN201710227618A CN107007755A CN 107007755 A CN107007755 A CN 107007755A CN 201710227618 A CN201710227618 A CN 201710227618A CN 107007755 A CN107007755 A CN 107007755A
Authority
CN
China
Prior art keywords
spray
bruise
raw material
ethanol
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710227618.5A
Other languages
English (en)
Inventor
王勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201710227618.5A priority Critical patent/CN107007755A/zh
Publication of CN107007755A publication Critical patent/CN107007755A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

一种跌打喷雾剂的制备方法，通过原料制备和在乙醇液体中的浸泡混合制得，该喷雾剂主治各种跌打损伤如：闭合性软组织挫伤、骨折及关节脱位局部肿痛、外伤局部伤口出血、屈指肌腱狭窄性腱鞘炎等，亦可治疗风湿性关节炎，痛风性关节炎，蜂窝组织炎。

Description

一种跌打喷雾剂的制备方法
技术领域
本发明涉及一种跌打喷雾剂的配制方法。
背景技术
跌打损伤主要包括由于跌扑、刀伤、殴打、闪压、擦伤以及运动损伤等导致局部或者全身的疼痛、肿胀、伤筋、踊损、出血、皮肤青紫等外伤现象，也包括呼吸时内部刺痛等内脏损伤。现有治疗跌打损伤的药物主要有风痛灵、酸痛灵喷剂等，它们的优点是使用简单，携带方便；但是效果不是很明显。
本发明的跌打喷雾剂的功用主治为消炎消肿、活血化瘀、驱风除湿，治疗范围包括各种跌打损伤如：闭合性软组织挫伤、骨折及关节脱位局部肿痛、外伤局部伤口出血等，亦可治疗风湿性关节炎，痛风性关节炎，蜂窝组织炎，使用方便，效果明显。
发明内容
本发明采用如下技术方案一种跌打喷雾剂的制备方法，其特征在于，该方法包括以下步骤:
步骤1:原料制备，按质量比为生地10-15，三七2-5，红花10-20，樟脑10-20g，薄荷脑1-5，冰片0.1-0.5g，血竭10-20g，大黄：10-100，黄连10-100，黄柏10-100，黄芩10-100g，黄栀子10-100，见血清10-100，备用；
步骤2，将步骤1所制得的原料采用5层纱布包裹后放入有刻度的玻璃容器内，加入95％乙醇，所述原料与乙醇的质量体积比为1：3，在常温28-29℃下将上述原料和乙醇泡10-20天；
步骤3:从玻璃容器内倒出浸泡好的呈深褐色液体；
步骤4:将深褐色液体分装入120ml容量的喷雾瓶内，得到跌打喷雾剂。
步骤1中所述原料制备，按质量比为生地12，三七3.6，红花12，樟脑12，薄荷脑3.6，冰片0.25，血竭12，大黄50，黄连50，黄柏50，黄芩50，黄栀子50，见血清25。
有益效果：
1、社会效益及技术效果：骨折、关节脱位、韧带及肌腱肌肉等软组织损伤后，活血化瘀、消肿等外用药物有助于消肿、有助于损伤组织的功能恢复、结构恢复，有助于患者早日康复。很多患者，特别是老年患者，因长时间患有消化系统疾病或高血压、糖尿病等其他慢性疾病，肠胃功能不好，活血化瘀、消肿等口服药物可能诱发或加重胃溃疡、胃出血，可能引起血压升高、血糖波动等副作用，甚至有的口服或药物针剂引发药物过敏、肾功能衰竭等。研究者上研究生期间,就曾经遇到过一例患者因口服一种活血化瘀、消肿的口服胶囊两个月，导致慢性肾功能衰竭，最后不得不长期做血液透析，因高额的医疗费用，家贫如洗。
应用该跌打喷雾剂，局部应用活血化瘀、消肿等外用药物，有利于尽快消除软组织水肿、骨膜水肿，有利于损伤组织的功能恢复、结构恢复；且局部外用活血化瘀、消肿等外用药物，因其对胃肠等消化系统器官以及对泌尿系统等器官的功能影响、结构影响极小，可以减少活血化瘀、消肿、止痛等口服药物可能诱发或加重的胃溃疡、胃出血、血压升高、血糖波动等副作用，能够通过控制药物的体内摄入量、吸收量而避免可能引发的药物过敏、肾功能衰竭等。
该跌打喷雾剂治疗骨折、关节脱位、韧带及肌腱肌肉等软组织损伤的保守治疗方法，与传统手术治疗所用的几百、几千甚至上万的内固定钢板、螺钉、钛棒相比，成本很低(每瓶100ml不超过一百元)，能够为国家节省大量的医保报销费用，能够在很大程度上减轻患者医保自负费用的经济负担。
2、经济效益：该跌打喷雾剂，可转化为新型实用、能够产生经济效益的中成药类商品，其功用主治为活血化瘀、消肿止痛、驱风除湿，其治疗范围包括各种跌打损伤如：闭合性软组织挫伤、骨折及关节脱位局部肿痛、外伤局部伤口出血等，亦可治疗风湿性关节炎，痛风性关节炎，蜂窝组织炎，其使用科室包括综合性医院或专科医院的骨科、康复科、针灸理疗科等相关科室，可以在诊所等其它医疗机构使用，可以在药店销售，其潜在的经济效益、社会效益是巨大的。
具体实施方式
下面结合具体实施例，进一步阐述本发明。
一种跌打喷雾剂的制备方法，其特征在于，该方法包括以下步骤:
步骤1:原料制备，按质量比为生地10-15，三七2-5，红花10-20，樟脑10-20g，薄荷脑1-5，冰片0.1-0.5g，血竭10-20g，大黄：10-100，黄连10-100，黄柏10-100，黄芩10-100g，黄栀子10-100，见血清10-100，备用；
步骤2，将步骤1所制得的原料采用5层纱布包裹后放入有刻度的玻璃容器内，加入95％乙醇，所述原料与乙醇的质量体积比为1：3，在常温28-29℃下将上述原料和乙醇泡10-20天；
步骤3:从玻璃容器内倒出浸泡好的呈深褐色液体；
步骤4:将深褐色液体分装入120ml容量的喷雾瓶内，得到跌打喷雾剂。
步骤1中所述原料制备，按质量比为生地12，三七3.6，红花12，樟脑12，薄荷脑3.6，冰片0.25，血竭12，大黄50，黄连50，黄柏50，黄芩50，黄栀子50，见血清25。
使用该跌打喷雾剂时，将瓶内药液摇匀，将喷嘴正对伤处15～25cm,用手指按压喷头，将药液喷在患处5～8层(层间干后再喷涂下一层)，每日2～3次。
研究目的：评价本跌打喷雾剂治疗闭合性软组织挫伤、骨折、关节脱位伴局部软组织肿痛、风湿性关节炎、痛风性关节炎、四肢局部蜂窝组织炎的临床疗效。
研究方法：将闭合性软组织挫伤120例、骨折36例、关节脱位伴局部软组织肿痛26例、风湿性关节炎52例、痛风性关节炎67例、四肢局部蜂窝组织炎30例纳入临床疗效研究。临床疗效评价指标包括：疼痛评分(0-6分)、肿胀评分(0-3分)、瘀斑评分(0-3分)、功能障碍(0-3分)。
研究结果：各治疗组在治疗后3d、6d、9d的愈显率、总有效率有显著性意义(P＜0.05)。在镇痛作用方面，各治疗组在治疗3d、6d、9d后的疼痛评分明显低于治疗前(P＜0.05)；在消肿、消瘀、促进肢体关节功能恢复方面，疗效评价具有有显著性意义(P＜0.05)。在毒副作用方面，四肢局部蜂窝组织炎组30例中有2例用药后局部有脱皮现象，痛风性关节炎治疗组67例中有3例患者用药过程中局部皮肤出现瘙痒(局部涂抹皮炎平软膏后缓解)。全部患者局部皮肤均未出现红疹、水泡等副作用。
研究结论：本跌打喷雾剂对闭合性软组织挫伤、骨折、关节脱位伴局部软组织肿痛、风湿性关节炎、痛风性关节炎、四肢局部蜂窝组织炎的治疗，在缓解疼痛、消肿、散瘀、促进肢体关节功能恢复方面具有良好的疗效，且本跌打喷雾剂对皮肤刺激性小，未出现严重皮肤过敏反应，总体来讲是安全、有效的。
应理解，这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解，在阅读了本发明讲授的内容之后，本领域技术人员可以对本发明作各种改动或修改，这些等价形式同样落于本申请所附权利要求书所限定的范围。

Claims (2)

1.一种跌打喷雾剂的制备方法，其特征在于，该方法包括以下步骤:
步骤1:原料制备，按质量比为生地10-15，三七2-5，红花10-20，樟脑10-20g，薄荷脑1-5，冰片0.1-0.5g，血竭10-20g，大黄：10-100，黄连10-100，黄柏10-100，黄芩10-100g，黄栀子10-100，见血清10-100，备用；
步骤2，将步骤1所制得的原料采用5层纱布包裹后放入有刻度的玻璃容器内，加入95％乙醇，所述原料与乙醇的质量体积比为1：3，在常温28-29℃下将上述原料和乙醇泡10-20天；
步骤3:从玻璃容器内倒出浸泡好的呈深褐色液体；
步骤4:将深褐色液体分装入120ml容量的喷雾瓶内，得到跌打喷雾剂。
2.如权利要求1所述的一种跌打喷雾剂的制备方法，其特征在于，步骤1中所述原料制备，按质量比为生地12，三七3.6，红花12，樟脑12，薄荷脑3.6，冰片0.25，血竭12，大黄50，黄连50，黄柏50，黄芩50，黄栀子50，见血清25。
CN201710227618.5A 2017-04-10 2017-04-10 一种跌打喷雾剂的制备方法 Pending CN107007755A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710227618.5A CN107007755A (zh) 2017-04-10 2017-04-10 一种跌打喷雾剂的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710227618.5A CN107007755A (zh) 2017-04-10 2017-04-10 一种跌打喷雾剂的制备方法

Publications (1)

Publication Number Publication Date
CN107007755A true CN107007755A (zh) 2017-08-04

Family

ID=59446096

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710227618.5A Pending CN107007755A (zh) 2017-04-10 2017-04-10 一种跌打喷雾剂的制备方法

Country Status (1)

Country Link
CN (1) CN107007755A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115350228A (zh) * 2022-08-16 2022-11-18 何磊 一种治疗骨折的中药组合物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
吴灿光等: "HPLC法测定筋痛消酊中大黄素和", 《今日药学》 *
邹来勇等: "自拟黄药膏外敷治疗急性踝关节扭伤54例临床观察", 《江苏中医药》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115350228A (zh) * 2022-08-16 2022-11-18 何磊 一种治疗骨折的中药组合物

Similar Documents

Publication Publication Date Title
CN102091295B (zh) 一种治疗股骨头坏死的中药组合物及其制备方法
CN108743767A (zh) 一种活血化瘀外用药及其制备方法
CN1927286A (zh) 一种治疗皮肤病的中药组合物
CN102526433B (zh) 一种治疗关节挛缩的药物
CN104984191A (zh) 治疗急性腰扭伤的中药组合物
CN106983826A (zh) 一种跌打药膏的配制方法
CN107007755A (zh) 一种跌打喷雾剂的制备方法
CN103230535A (zh) 一种具有活络镇痛作用的药酒
CN103599438B (zh) 一种治疗骨病的中药酊及其制备方法
CN102755591B (zh) 一种治疗骨折的中药膏药
CN100551394C (zh) 治疗银屑病的药
CN105287731A (zh) 一种外敷治疗骨质增生的中药制剂及其制备方法
CN108686146A (zh) 一种活血化瘀外敷膏药及其制备方法
CN109966451A (zh) 一种正骨止痛的中药组合物
CN104367939A (zh) 一种治疗疑病性神经症的中药及其制备方法
CN107158126A (zh) 一种消炎止痛组合物
CN103610914B (zh) 一种治疗风湿性关节炎的内服中药酒
CN116173160B (zh) 一种外用消肿止痛组方及其应用
CN101313930A (zh) 一种治疗糜烂型手足癣的膏状药物
CN109806321B (zh) 一种中药组合物及其制法和在制备治疗外伤药物中的应用
CN106822313A (zh) 一种活血化瘀中药汤剂的制备方法
CN100406035C (zh) 一种治疗腰椎间盘突出症的中药制剂
CN104547915A (zh) 一种治疗跌打损伤的中药组合物及其药酒
CN108524741A (zh) 一种治疗骨关节病变的外用贴剂
CN1406600A (zh) 一种治疗骨质增生的药

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170804